SCHEMBL2803168

SCHEMBL2803168

CCCCCCONc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.46
EPHX1 P07099 3/20 0.44
ALDH1A1 P00352 2/20 0.44
HTT P42858 1/20 0.44
FAAH O00519 6/20 0.43
TSHR P16473 2/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPK1 P28482 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KCNH3 Q9ULD8 1/20 0.40
MLNR O43193 1/20 0.40
NR1I2 O75469 1/20 0.40
ESR1 P03372 1/20 0.40
NR3C1 P04150 1/20 0.40
PGR P06401 1/20 0.40
ADRB2 P07550 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18049455 1.00 LTA4H (0.46) LTA4HEPHX1ALDH1A1HTTFAAH
SCHEMBL7593121 1.00 LTA4H (0.46) LTA4HEPHX1ALDH1A1HTTFAAH
SCHEMBL8389397 1.00 LTA4H (0.46) LTA4HEPHX1ALDH1A1HTTFAAH
Benzene SCHEMBL27363600 1.00 LTA4H (0.46) LTA4HEPHX1ALDH1A1HTTFAAH
SCHEMBL3523840 1.00 LTA4H (0.46) LTA4HEPHX1ALDH1A1HTTFAAH
SCHEMBL9169265 1.00 LTA4H (0.46) LTA4HEPHX1ALDH1A1HTTFAAH
SCHEMBL11672538 1.00 LTA4H (0.46) LTA4HEPHX1ALDH1A1HTTFAAH
SCHEMBL905673 1.00 LTA4H (0.46) LTA4HEPHX1ALDH1A1HTTFAAH
Hydrochloric Acid SCHEMBL4942620 0.98 LTA4H (0.44) LTA4HEPHX1ALDH1A1HTTFAAH
Hydrochloric Acid SCHEMBL28569833 0.98 LTA4H (0.44) LTA4HEPHX1ALDH1A1HTTFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10011684-B2 Arylamine polymer, method for producing the same, ink composition, film, electronic device, organic thin-film transistor, and display device RICOH COMPANY, LTD. (JP) 2018-07-03 US disclosed
US-20150284511-A1 NOVEL ARYLAMINE POLYMER, METHOD FOR PRODUCING THE SAME, INK COMPOSITION, FILM, ELECTRONIC DEVICE, ORGANIC THIN-FILM TRANSISTOR, AND DISPLAY DEVICE SAGISAKA TOSHIYA (JP) 2015-10-08 US disclosed
CN-102036992-B Switchable special effect substances BASF SE 2014-11-26 CN disclosed
EP-2188322-B1 NOVEL ARYLAMINE POLYMER, METHOD FOR PRODUCING THE SAME, INK COMPOSITION, FILM, ELECTRONIC DEVICE, ORGANIC THIN-FILM TRANSISTOR, AND DISPLAY DEVICE RICOH CO LTD (JP) 2013-05-22 EP disclosed
US-20100219405-A1 NOVEL ARYLAMINE POLYMER, METHOD FOR PRODUCING THE SAME, INK COMPOSITION, FILM, ELECTRONIC DEVICE, ORGANIC THIN-FILM TRANSISTOR, AND DISPLAY DEVICE RICOH COMPANY, LTD. (JP) 2010-09-02 US disclosed
CN-101724409-A Liquid crystal orientation agent, liquid crystal orientation film and forming method thereof, liquid crystal display component and polymer JSR CORP 2010-06-09 CN disclosed
EP-2188322-A1 NOVEL ARYLAMINE POLYMER, METHOD FOR PRODUCING THE SAME, INK COMPOSITION, FILM, ELECTRONIC DEVICE, ORGANIC THIN-FILM TRANSISTOR, AND DISPLAY DEVICE Ricoh Company, Ltd. (JP) 2010-05-26 EP disclosed
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
WO-2009035133-A1 NOVEL ARYLAMINE POLYMER, METHOD FOR PRODUCING THE SAME, INK COMPOSITION, FILM, ELECTRONIC DEVICE, ORGANIC THIN-FILM TRANSISTOR, AND DISPLAY DEVICE RICOH COMPANY, LTD. (JP) 2009-03-19 WO disclosed
CN-101255170-A 2,3-dihydroimidazo[2,1-b]oxazole compound OTSUKA PHARMA CO LTD (JP) 2008-09-03 CN disclosed
CN-100366624-C 2, 3-dihydro-6-nitroimidazo [2,1-b ] * azole compounds OTSUKA PHARMA CO LTD (JP) 2008-02-06 CN disclosed
CN-100344731-C Liquid crystal aligning agent and liquid crystal display element JSR CORP (JP) 2007-10-24 CN disclosed
WO-2007019503-A2 MANAGEMENT OF OPHTHALMOLOGIC DISORDERS, INCLUDING MACULAR DEGENERATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2007-02-15 WO disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed
CN-1721502-A Liquid crystal aligning agent and liquid crystal display element JSR CORP (JP) 2006-01-18 CN disclosed
CN-1705670-A 2, 3-dihydro-6-nitroimidazo [2, 1-b ] oxazole compounds OTSUKA PHARMA CO LTD (JP) 2005-12-07 CN disclosed
CN-1408817-A Liquid crystal aligning agent and liquid crystal display element JSR CORP (JP) 2003-04-09 CN disclosed
US-5167857-A Optically active, optical modulation CANON KABUSHIKI KAISHA (JP) 1992-12-01 US disclosed
EP-0175591-B1 LACTIC ACID DERIVATIVE, LIQUID CRYSTAL COMPOSITION CONTAINING SAME AND LIQUID CRYSTAL DEVICE CANON KABUSHIKI KAISHA (JP) 1991-03-06 EP disclosed
US-4775223-A DISPLAY DEVICE CANON KABUSHIKI KAISHA (JP) 1988-10-04 US disclosed